13G Filing: Great Point Partners and Adamas Pharmaceuticals Inc (ADMS)

Page 7 of 8 – SEC Filing

CUSIP
No.  00548A106
13G/A Page
7 of 7 Pages

SIGNATURE

After reasonable inquiry and
to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: October 10, 2017

GREAT POINT PARTNERS, LLC
By:  /s/ Dr. Jeffrey R. Jay, M.D.
Dr. Jeffrey R. Jay, M.D.,
as senior managing member
  /s/ Dr. Jeffrey R. Jay, M.D.
DR. JEFFREY R. JAY, M.D.
  /s/ Mr. David Kroin
MR. DAVID KROIN

Follow Adamas Pharmaceuticals Inc (NASDAQ:ADMS)